IGC Pharma Inc. (IGC)
NYSE · Healthcare
IGC Pharma Inc. Shareholder Equity 2011–2025
IGC Pharma Inc. annual shareholder equity history from 2011 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- IGC Pharma Inc. shareholder equity as of March 31, 2025: 6.3M, a 13.54% decrease year-over-year.
- IGC Pharma Inc. shareholder equity for 2025 were 6.3M, a 13.54% decrease from 2024.
- IGC Pharma Inc. shareholder equity for 2024 were 7.3M, a 50.90% decrease from 2023.
- IGC Pharma Inc. shareholder equity for 2023 were 14.9M, a 37.59% decrease from 2022.
- IGC Pharma Inc. shareholder equity for 2022 were 23.9M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| IGC Pharma Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $6 |
| 2024 | $7 |
| 2023 | $15 |
| 2022 | $24 |
| 2021 | $33 |
| 2020 | $27 |
| 2019 | $34 |
| 2018 | $8 |
| 2017 | $7 |
| 2016 | $13 |
| 2015 | $14 |
| 2014 | $14 |
| 2013 | $14 |
| 2012 | $15 |
| 2011 | $7 |
IGC Pharma Inc. Shareholder Equity — FAQ
IGC Pharma Inc. (IGC) shareholder equity over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see IGC's shareholder equity history?
The chart and table above show IGC Pharma Inc.'s shareholder equity by year and by quarter, including the growth rate.